Research Grants and Contracts

2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002

2009

NHMRC Project Grant: KL Schmid, M Collins and JR Hanrahan 'GABAergic mechanisms in eye growth'. (2009-2011 $305,850)

NMMRC Equipment Grant: DE Hibbs, BD Roufogalis, M Murray, TW Hambly, JR Hanrahan, WB Church, M Collins, GAR Johnston, PM Young, D Traini 'Bruker APEX II CCD Detector Fourth Generation APEX II ultra-low noise CCD X-ray detector with 16 megapixel chip' $50,100 in 2009

ARC Discovery Grant: MD McLeod and M Collins 'Elucidating the mode of action of nicotinic receptor ligands'. (2009-2011 $420,000) $180,000 in 2009

2008

NHMRC Project Grant: GAR Johnston, JR Hanrahan, M Collins and KN Mewett. Positive modulation of ionotropic GABA receptors (2006-2008) $176.250 in 2008

NHMRC Equipment Grant: M Murray, JR Hanrahan, DE Hibbs, BD Roufogalis, M Collins, CC Duke, WB Church, IR Kennedy, GAR Johnston, DR Richardson, N Manolios, R Codd, RD Allan, M Kassiou, M Ali, M Tattam 'Varian NMR System 400MHz and autosampler' $100,000 in 2008

ARC Discovery Grant: MD McLeod and M Collins 'Elucidating the mode of action of nicotinic receptor ligands'. (2006-2008 $275,000) $95,000 in 2008

2007

NHMRC Project Grant: GAR Johnston, JR Hanrahan, M Collins and KN Mewett. Positive modulation of ionotropic GABA receptors (2006-2008) $176.250 in 2007

NH&MRC Project Grant: GAR Johnston, A Moorhouse and RK Duke. Cage compounds as blockers of GABA and glycine receptor channels (2005-2007). $170,500 in 2007

R&D Joint Venture between Neuro Therapeutics Ltd and The University of Sydney, JR Hanrahan, M Collins and GAR Johnston. GABA-C receptor antagonists for the treatment of memory disorders and myopia ($280,250 in 2006/7)

ARC Discovery Grant: MD McLeod and M Collins 'Elucidating the mode of action of nicotinic receptor ligands'. (2006-2008 $275,000) $95,000 in 2007

2006

NH&MRC Project Grant: GAR Johnston, A Moorhouse and RK Duke. Cage compounds as blockers of GABA and glycine receptor channels (2005-2007). $170,500 in 2006

NHMRC Project Grant: GAR Johnston, JR Hanrahan, M Collins and KN Mewett. Positive modulation of ionotropic GABA receptors (2006-2008) $176.250 in 2006

ARC LIEF Grant: T. Maschmeyer, S. Kable, P. Karuso, D. Gore, J.R. Aldrich-Wright, K. Downard, M.M. Harding, M. McLeod, K.A. Jolliffe, G.A.R. Johnston, J.R. Hanrahan & K.J. Fisher. To purchase a High Resolution Fourier Transform Ion Cyclotron Resonance Mass Spectrometer and a Carbon, Hydrogen Nitrogen and Sulfur Analyser for chemical characterization in the School of Chemistry. $1,400,000 in 2006

ARC Discovery Grant: MD McLeod and M Collins 'Elucidating the mode of action of nicotinic receptor ligands'. (2006-2008 $275,000) $95,000 in 2006

University of Sydney Bridging Grant: M Collins, KS Schmid, GAR Johnston and JR Hanrahan 'Antagonists for myopia control: pharmacology and retinal mechanisms' $23,000 in 2006

R&D Joint Venture between Neuro Therapeutics Ltd and The University of Sydney, JR Hanrahan, M Collins and GAR Johnston. GABA-C receptor antagonists for the treatment of memory disorders and myopia ($280,250 in 2006/7)

2005

NH&MRC Project Grant, GAR Johnston, A Moorhouse and RK Duke. Cage compounds as blockers of GABA and glycine receptor channels (2005-2007). $170,500 in 2005

Pfizer Global Research and Development (Australia) Research Contract: M Collins, JR Hanrahan and GAR Johnston, 'Constrained analogs of gabapentin and pregabalin' $379,350 in 2004/5

R&D Joint Venture between Polychip Pharmaceuticals and The University of Sydney, GAR Johnston, M Collins and J Hanrahan, Synthesis, testing and development of GABA-C antagonists, including cycopentane phosphinates, $196,928 2002-2005

2004

NH&MRC Project Grant, M Collins and GAR Johnston, The pharmacology and physiology of GABA-C receptors (2002-2004), $160,000 in 2004

NH&MRC Project grant: GAR Johnston and M Collins. GABA receptor modulation by flavonoids. $170,000 in 2004

ARC LIEF Grant: M Collins, M. McLeod, GAR Johnston, J Jamie and R Read. Robocyte functional screening facility. $110,000 in 2004

Pfizer Global Research and Development (Australia) Research Contract: M Collins, JR Hanrahan and GAR Johnston, 'Constrained analogs of gabapentin and pregabalin' $379,350 in 2004/5

.R&D Joint Venture between Polychip Pharmaceuticals and The University of Sydney, GAR Johnston, M Collins and J Hanrahan, Synthesis, testing and development of GABA-C antagonists, including cycopentane phosphinates, $196,928 2002-2005

2003

NH&MRC Project Grant: M Collins and GAR Johnston, The pharmacology and physiology of GABA-C receptors (2002-2004), $160,000 in 2003

Pfizer Global Research and Development (Australia) Research Contract: M Collins, JR Hanrahan and GAR Johnston, 'Constrained analogs of gabapentin and pregabalin' $379,350 in 2003

2002

Australian Research Council Linkage-Infrastructure Grant : R. Read (UNSW), M Collins (UoS) and J Jamie (MacquarieU), The Sydney Combinatorial Research Facility, $590,000 in 2002

NH&MRC Project Grant: M Collins and GAR Johnston, The pharmacology and physiology of GABA-C receptors (2002-2004), $160,000 in 2002

NH&MRC Project grant: GAR Johnston and M Collins, Flavonoids and GABA receptors (2000-2002) $140,524 in 2002

Rebecca Cooper Medical Research Foundation Grant: M Collins, The effects of anti-psychotics on GABA-A and GABA-C receptor subtypes, $10,255 in 2002

University of Sydney Sesqui Grant : GAR Johnston & M Collins, Cage compounds, GABA & glycine receptors, $50,000 in 2002.

R&D Joint Venture between Polychip Pharmaceuticals and The University of Sydney, GAR Johnston, M Collins and J Hanrahan, Synthesis, testing and development of GABA-C antagonists, including cycopentane phosphinates, $196,928 in 2002.